Seal Rock Therapeutics
Seattle, US · Delaware corporation
Sealrock is a drug development company whose team has worked on the discovery, development, and commercialization of FDA-approved drugs. It focuses on pharmaceutical research and translational medicine.
Founders & leadership
KE
Kathleen EliasVP of Research & Translational Medicine / Co-Founder
NM
Neil McDonnellChief Executive Officer / Co-Founder
KW
Keith WycoffNamed on SEC filing
AP
Artur PlonowskiChief Scientific Officer / Co-Founder
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2022
▶$2.5MraisedFeb 2022 · 16 investors · OtherRule 506(b)
▶$2.5MraisedFeb 2022 · 16 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Neil McDonnellExecutive Officer, Director, Promoter
- Keith WycoffDirector
- Artur PlonowskiExecutive Officer, Director, Promoter
- Offering amount
- $6M
- Amount sold
- $2.5M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Scholar Rock3 shared keywordsScholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases. The company uses a selective protein targeting approach designed to inhibit disease mechanisms rather than manage their downstream effects.
Allrockbio3 shared keywordsAllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions. Its lead program is an orally administered pan-ROCK inhibitor being investigated in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease.
Doximity3 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies competing with Seal Rock Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $358.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Seal Rock Therapeutics do?
- Sealrock is a drug development company whose team has worked on the discovery, development, and commercialization of FDA-approved drugs. It focuses on pharmaceutical research and translational medicine.
- Who founded Seal Rock Therapeutics?
- Seal Rock Therapeutics was founded by Kathleen Elias.
- How much funding has Seal Rock Therapeutics raised?
- Seal Rock Therapeutics has disclosed $2.5M raised across 1 round.
- Where is Seal Rock Therapeutics headquartered?
- Seal Rock Therapeutics is headquartered in Seattle, US.